Christopher W. V. James
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christopher W. V. James has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Amirreza Aghakhani
Institute of Biomaterials and Biomolecular Systems University of Stuttgart Stuttgart Germany
1 shared publication - Hamed Shahsavan
University of Waterloo
1 shared publication - Irving Hafed Tejedor García
Department of Chemical Engineering University of Waterloo Waterloo Ontario Canada
1 shared publication - Joel Torres-Andrés
Departament de Ciència de Materials i Química Física Institute of Nanoscience and Nanotechnology (IN2UB) Universitat de Barcelona Barcelona Spain
1 shared publication Jordi Ignés‐Mullol
Departament de Ciència de Materials i Química Física Institute of Nanoscience and Nanotechnology (IN2UB) Universitat de Barcelona Barcelona Spain
1 shared publication- Josep Puigmartí-Luis
Departament de Ciència de Materials i Química Física Institut De Química Teòrica i Computacional Universitat De Barcelona Barcelona Spain
1 shared publication
Latest Publications
- Open Access
- 15 February 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (24) , e16677
Porous Hybrid Soft Actuators From Liquid Crystal Networks and Lyotropic Chromonic Liquid Crystal Templated Hydrogels
Liquid crystal networks (LCNs) have shown great utility in soft robotics as artificial muscles. Yet, their potential in biomedical applications, such as drug delivery, remains largely untapped. This can be partly attributed to LCNs’ limited compatibility with biological environments, and non‐porous microstructure and morphology. The current study focuses on developing actuators with improved porosity by creating constructs based on LCNs hybridized with liquid crystal hydrogels (LCHs). In our design, LCNs provide mechanical integrity and stimuli‐responsiveness, while LCHs introduce structural porosity and precise control over deformation. To manipulate LCHs’ microstructure and program the deformation of hybrid actuators, we used magnetically aligned lyotropic chromonic liquid crystals (LCLC) derived from disodium cromoglicate (DSCG) to template desired morphologies in acrylamide (AAM)‐based LCHs. Our results revealed that the integration of LCHs into LCNs dramatically increases the porosity of the construct. Interestingly, the distinct alignment and stimuli‐responsiveness of LCN and LCH layers can be leveraged to obtain complex programmable deformation. We believe that the inherent porosity and biocompatibility of LCHs can be used to expand the application of LCNs in therapeutic delivery and in enabling safer interaction with biological tissues, positioning them as promising materials for use in minimally invasive medical devices and adaptive implants.
- 15 February 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (24) , e16677
Open AccessPorous Hybrid Soft Actuators From Liquid Crystal Networks and Lyotropic Chromonic Liquid Crystal Templated Hydrogels
Liquid crystal networks (LCNs) have shown great utility in soft robotics as artificial muscles. Yet, their potential in biomedical applications, such as drug delivery, remains largely untapped. This can be partly attributed to LCNs’ limited compatibility with biological environments, and non‐porous microstructure and morphology. The current study focuses on developing actuators with improved porosity by creating constructs based on LCNs hybridized with liquid crystal hydrogels (LCHs). In our design, LCNs provide mechanical integrity and stimuli‐responsiveness, while LCHs introduce structural porosity and precise control over deformation. To manipulate LCHs’ microstructure and program the deformation of hybrid actuators, we used magnetically aligned lyotropic chromonic liquid crystals (LCLC) derived from disodium cromoglicate (DSCG) to template desired morphologies in acrylamide (AAM)‐based LCHs. Our results revealed that the integration of LCHs into LCNs dramatically increases the porosity of the construct. Interestingly, the distinct alignment and stimuli‐responsiveness of LCN and LCH layers can be leveraged to obtain complex programmable deformation. We believe that the inherent porosity and biocompatibility of LCHs can be used to expand the application of LCNs in therapeutic delivery and in enabling safer interaction with biological tissues, positioning them as promising materials for use in minimally invasive medical devices and adaptive implants.